Voyager Therapeutics, Inc. VYGR
1.96 USD +0.24 (+13.66%)
Nov 6, 2026, 3:06 PM EST
1.72 Day range 1.96
1.68 52-week range 5.48
- YTD
- -50.25%
- 1 year
- -53.67%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 40.37M | 80.00M | 250.01M | 40.91M | 37.41M | |
| 40.37M | 80.00M | 250.01M | 40.91M | 37.41M | |
| -131.84M | -83.29M | 122.01M | -50.84M | -73.62M | |
| -119.72M | -65.00M | 132.33M | -46.41M | -71.20M | |
| -2.04 | -1.13 | 2.97 | -1.21 | -1.89 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 68.04M | 74.24M | 70.39M | 98.96M | 117.43M | |
| 252.28M | 393.05M | 351.28M | 159.36M | 193.85M | |
| 56.20M | 93.29M | 114.96M | 100.34M | 98.80M | |
| 36.50M | 43.73M | 20.29M | 0 | 0 | |
| 196.08M | 299.76M | 236.32M | 59.02M | 95.06M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -132.47M | -15.31M | 77.92M | -12.51M | -53.52M | |
| 125.45M | -94.86M | -141.64M | -7.34M | 65.91M | |
| 816.00K | 114.02M | 33.65M | 1.11M | 612.00K | |
| -2.60M | -3.52M | -3.26M | -2.49M | -1.61M | |
| -6.21M | 3.85M | -30.08M | -18.74M | 12.99M |